Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults. In June, the ACR released an updated guideline on the management of rheumatoid arthritis, which includes new recommendations for specific high-risk groups.1 The guideline includes 44 recommendations—seven of which are strong and 37 conditional. It underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. Learn more in our article below.
Plus, a vast repository of new research related to RA was presented to participants during ACR Convergence 2020. To help you sort through the noise, Elizabeth (Blair) Solow, MD, an assistant professor of medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center, Dallas, reviewed the abstracts and presents her picks for the top research in RA.
In this resource center, explore The Rheumatologist’s collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of RA. New features are added often, so check back frequently.
FEATURED ARTICLE: Experts Discuss Unique Challenges Posed by Difficult-to-Treat RA